C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/18 (2006.01) A61K 39/395 (2006.01) A61P 7/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 14/47 (2006.01) C12N 5/18 (2006.01)
Patent
CA 2622575
The present invention provides methods of using PROK2 and PROK1 antagonist, including monoclonal antibodies to treat inflammation, angiogenesis, and cancer.
La présente invention porte sur des méthodes d'utilisation de l'antagoniste PROK2 et PROK1 comprenant des anticorps monoclonaux pour traiter l'inflammation, l'angiogenèse et le cancer.
Brasel Kenneth
Franklin Henry R.
Fruebis Joachim
Noriega Claire R.
Oguz Secil
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Zymogenetics Inc.
LandOfFree
Prok2 antagonists and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prok2 antagonists and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prok2 antagonists and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1618166